2-Deoxy-D-glucose Sensitizes Cancer Cells to Barasertib and Everolimus by ROS-independent Mechanism(s)

Anticancer research

Volumn 35, Issue 12, 2015, Pages 6623-6632

  Zhelev, Zhivko ^a   Ivanova, Donika ^a   Aoki, Ichio ^a   Saga, Tsuneo ^a   Bakalova, Rumiana ^a  

^a UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

2 deoxy D glucose; Anticancer drugs; apoptosis; reactive oxygen species; synergism

Indexed keywords

2-((3-((4-((5-(2-((3-FLUOROPHENYL)AMINO)-2-OXOETHYL)-1H-PYRAZOL-3-YL)AMINO)QUINAZOLIN-7-YL)OXY)PROPYL)(ETHYL)AMINO)ETHYL DIHYDROGEN PHOSPHATE; DEOXYGLUCOSE; EVEROLIMUS; ORGANOPHOSPHATE; QUINAZOLINE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; DRUG POTENTIATION; HUMAN; JURKAT CELL LINE; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; DEOXYGLUCOSE; DRUG SYNERGISM; EVEROLIMUS; HUMANS; JURKAT CELLS; ORGANOPHOSPHATES; QUINAZOLINES; REACTIVE OXYGEN SPECIES;

EID: 84982298279     PISSN: None     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (0)